Researchers at Houston’s Baylor College of Medicine began Phase 2 clinical trials for a Zika vaccine that is expected to have results as early as the end of this year. The first part of phase 2 will have 90 healthy volunteers vaccinated to determine the optimal dose and injection site of the vaccine.

For more information, click here